EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is Sartorius (XTRA:SRT3) Undervalued Or Is AI Growth Already Priced In?
Global Drug Discovery Technology Market Analysis and Forecast 2026-2030 | AI, Precision Medicine, and Digital Biology Drive USD 31.56 Billion Growth at 9.1% CAGR
Global Cell Culture Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on Biologics and Personalized Medicine with Thermo Fisher, Merck, Lonza and Sartorius
Continuous Bioprocessing Market 2026: Global Size, Share, Trends, and Forecast to 2030 | Capitalize on 21.5% CAGR with Thermo Fisher, Danaher, Merck KGaA, Sartorius, and Lonza
Global Industrial Bioprocessing Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on 9% CAGR with Thermo Fisher, Danaher, Merck and Sartorius
Global Bioprocessing Monitoring Market Report 2026 | Capitalize on $18.63B by 2030 as Thermo Fisher, Danaher, Sartorius and Repligen Accelerate Real-Time PAT
Global Bioprocessing Supplies Market Report 2026: Size, Share, Trends, and Forecast to 2030 | Capitalize on Single-Use Scale with Thermo Fisher, Danaher, Merck, Sartorius
Global Bioprocess Automation Market Opportunities and Strategies to 2035 | Capitalize on AI, Perfusion and Single-Use Growth with Thermo Fisher, Danaher, Sartorius and Lonza
Is Sartorius (XTRA:SRT3) Fairly Valued Or Is Its 91% P/E Premium Too High?
Sartorius, MAbSilico join forces to accelerate AI-driven cell line development
Citigroup's Scott Sartorius Leaves for Commerce Department
Is Sartorius (XTRA:SRT3) Undervalued As Its Dublin Training Hub Draws Investor Attention?
Sartorius Well Positioned To Benefit From Biopharma Industry Recovery | Morningstar
Sartorius (OTCMKTS:SARTF) Trading 7.4% Higher - Time to Buy? - Stock Observer
Sartorius (XTRA:SRT3) Could Be 21% Below Fair Value On Dublin Training Push
Sartorius (OTCMKTS:SARTF) Shares Gap Up - Still a Buy? - Zolmax
